{
    "title": "Novartis faces delay after FDA asks for another Zolgensma study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8763235/Novartis-faces-delay-FDA-asks-Zolgensma-study.html",
    "date": "2020-09-23",
    "keywords": [
        "zolgensma",
        "study",
        "novartis",
        "approval",
        "miller",
        "gene",
        "drug",
        "infusion",
        "request",
        "fda",
        "therapys",
        "analyst",
        "michael",
        "bid",
        "therapy",
        "atrophy",
        "delay",
        "wednesday",
        "trading",
        "food",
        "safety",
        "hold",
        "trial",
        "damage",
        "year",
        "company",
        "move",
        "condition",
        "medicine",
        "evrysdi",
        "market",
        "development",
        "peak",
        "revenue",
        "forecast",
        "zuercher",
        "note",
        "fdas",
        "call",
        "avexis",
        "treatment",
        "benefitrisk",
        "potential",
        "population",
        "confirmatory",
        "support",
        "filing",
        "reporting",
        "john",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}